Milestone Pharmaceuticals
MIST
MIST
40 hedge funds and large institutions have $30.9M invested in Milestone Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3.4% less ownership
Funds ownership: 58.63% → 55.24% (-3.4%)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
49% less capital invested
Capital invested by funds: $60.7M → $30.9M (-$29.8M)
Holders
40
Holding in Top 10
2
Calls
$411K
Puts
$160K
Top Buyers
| 1 | +$2M | |
| 2 | +$1.13M | |
| 3 | +$827K | |
| 4 |
BlackRock
New York
|
+$818K |
| 5 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$284K |
Top Sellers
| 1 | -$2.14M | |
| 2 | -$2.01M | |
| 3 | -$1.04M | |
| 4 |
Barclays
London,
United Kingdom
|
-$652K |
| 5 |
JPMorgan Chase & Co
New York
|
-$390K |